CareRx Corporation
CHHHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $366,714 | $370,746 | $381,727 | $262,630 |
| % Growth | -1.1% | -2.9% | 45.3% | – |
| Cost of Goods Sold | $258,654 | $266,048 | $271,793 | $187,351 |
| Gross Profit | $108,060 | $104,698 | $109,934 | $75,279 |
| % Margin | 29.5% | 28.2% | 28.8% | 28.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $32,752 | $30,662 | $34,432 | $25,131 |
| SG&A Expenses | $32,752 | $30,662 | $34,432 | $25,131 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $70,783 | $69,366 | $67,869 | $45,337 |
| Operating Expenses | $103,535 | $100,028 | $102,301 | $70,468 |
| Operating Income | $4,525 | $4,670 | $7,911 | $4,714 |
| % Margin | 1.2% | 1.3% | 2.1% | 1.8% |
| Other Income/Exp. Net | -$8,994 | -$14,265 | -$13,952 | -$20,428 |
| Pre-Tax Income | -$4,469 | -$9,595 | -$35,896 | -$23,735 |
| Tax Expense | $32 | -$4,190 | -$1,543 | -$1,005 |
| Net Income | -$4,501 | -$5,405 | -$34,353 | -$22,730 |
| % Margin | -1.2% | -1.5% | -9% | -8.7% |
| EPS | -0.075 | -0.094 | -0.72 | -0.65 |
| % Growth | 20.5% | 86.9% | -10.8% | – |
| EPS Diluted | -0.075 | -0.094 | -0.72 | -0.65 |
| Weighted Avg Shares Out | 60,131 | 57,350 | 47,596 | 34,858 |
| Weighted Avg Shares Out Dil | 60,131 | 57,350 | 47,596 | 34,858 |
| Supplemental Information | – | – | – | – |
| Interest Income | $63 | $1,257 | $278 | $58 |
| Interest Expense | $9,182 | $14,270 | $15,221 | $14,492 |
| Depreciation & Amortization | $19,190 | $19,976 | $20,065 | $15,393 |
| EBITDA | $23,903 | $24,651 | -$610 | $20,107 |
| % Margin | 6.5% | 6.6% | -0.2% | 7.7% |